Resultado de búsqueda
Hace 4 días · Dive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy production. Merck KGaA is making the purchase through its U.S. and Canadian life sciences unit, MilliporeSigma.
Hace 4 días · Merck KGaA and its CDMO arm MilliporeSigma are increasing their presence in gene therapy manufacturing with a $600 million buyout of Mirus Bio.
Hace 4 días · See you at BIO: China tensions, fixing gene therapy’s business model, and the stop-start market recovery. Drew Armstrong Executive Editor. In two weeks, ...
Hace 4 días · Oct. 14, 2019 — Scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia (FTD), adding to growing evidence that the ...
Hace 5 días · Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
Hace 5 días · Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to develop one or even a handful of world-changing drugs to address ...
Hace 5 días · New 'Atlas' Provides Unprecedented Insights on How Genes Function in Early Embryo Development. May 23, 2024 — Biologists have provided new insights on a longstanding puzzle in biology: How ...